BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ning G, Zhen LM, Xu WX, Li XJ, Wu LN, Liu Y, Xie C, Peng L. Suppression of complement component 2 expression by hepatitis B virus contributes to the viral persistence in chronic hepatitis B patients. J Viral Hepat 2020;27:1071-81. [PMID: 32384193 DOI: 10.1111/jvh.13319] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Fan J, Chen Y, Zhang W, Zhou X, Bai X, Chang C, Han Y, Liu J, Yang J. Identification of the Hub Genes and Potential Regulation Network in Chronic Hepatitis B via Bioinformatics Analysis. Disease Markers 2022;2022:1-12. [DOI: 10.1155/2022/6113807] [Reference Citation Analysis]
2 Boldt ABW, Oliveira-Toré CF, Kretzschmar GC, Weinschutz Mendes H, Stinghen ST, Andrade FA, Bumiller-Bini V, Gonçalves LB, Braga ACM, Stahlke EVRS, Velavan TP, Thiel S, de Messias-Reason IJT. Hepatitis B Virus Infection Among Leprosy Patients: A Case for Polymorphisms Compromising Activation of the Lectin Pathway and Complement Receptors. Front Immunol 2020;11:574457. [PMID: 33643280 DOI: 10.3389/fimmu.2020.574457] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wu G, Xu Y, Han C, Wang Z, Li J, Wang Q, Che X. Identification of a Prognostic Risk Signature of Kidney Renal Clear Cell Carcinoma Based on Regulating the Immune Response Pathway Exploration. J Oncol 2020;2020:6657013. [PMID: 33456463 DOI: 10.1155/2020/6657013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]